These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2963852

  • 1. Effects of atrial natriuretic peptide on coronary vascular resistance in the intact awake dog.
    Laxson DD, Dai XZ, Schwartz JS, Bache RJ.
    J Am Coll Cardiol; 1988 Mar; 11(3):624-9. PubMed ID: 2963852
    [Abstract] [Full Text] [Related]

  • 2. Effects of atrial natriuretic peptide in the canine coronary circulation.
    Bache RJ, Dai XZ, Schwartz JS, Chen DG.
    Circ Res; 1988 Jan; 62(1):178-83. PubMed ID: 2961478
    [Abstract] [Full Text] [Related]

  • 3. Effects of atrial natriuretic peptide on proximal epicardial coronary arteries and coronary blood flow in conscious dogs.
    Chu A, Cobb FR.
    Circ Res; 1987 Oct; 61(4):485-91. PubMed ID: 2958167
    [Abstract] [Full Text] [Related]

  • 4. Effect of atrial natriuretic peptide on coronary collateral blood flow.
    Foreman B, Dai XZ, Homans DC, Laxson DD, Bache RJ.
    Circ Res; 1989 Dec; 65(6):1671-8. PubMed ID: 2531047
    [Abstract] [Full Text] [Related]

  • 5. Sustained dilatation of large coronary artery by alpha-human atrial natriuretic peptide in conscious dogs: a comparison with nitroglycerin.
    Adachi H, Tomoike H, Nishijima H, Egashira S, Nakamura M.
    Eur J Pharmacol; 1989 Feb 28; 161(2-3):189-96. PubMed ID: 2524391
    [Abstract] [Full Text] [Related]

  • 6. Effect of atrial natriuretic factor on transmural myocardial blood flow distribution in the dog.
    Bauman RP, Rembert JC, Himmelstein SI, Klotman PE, Greenfield JC.
    Circulation; 1987 Sep 28; 76(3):705-9. PubMed ID: 2957114
    [Abstract] [Full Text] [Related]

  • 7. Preferential proximal coronary dilation by activators of guanylate cyclase in awake dogs.
    Chu A, Murray JJ, Lin CC, Russell M, Hagen PO, Cobb FR.
    Am J Physiol; 1990 Aug 28; 259(2 Pt 2):H340-5. PubMed ID: 1974738
    [Abstract] [Full Text] [Related]

  • 8. Coronary vasoconstrictor effects of atriopeptin II.
    Wangler RD, Breuhaus BA, Otero HO, Hastings DA, Holzman MD, Saneii HH, Sparks HV, Chimoskey JE.
    Science; 1985 Nov 01; 230(4725):558-61. PubMed ID: 2931801
    [Abstract] [Full Text] [Related]

  • 9. Effects of atrial natriuretic factor on blood flow distribution and vascular resistance in conscious dogs.
    Shen YT, Graham RM, Vatner SF.
    Am J Physiol; 1991 Jun 01; 260(6 Pt 2):H1893-902. PubMed ID: 1829333
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of infusion versus bolus administration of atrial natriuretic factor.
    Lappe RW, Todt JA, Wendt RL.
    Hypertension; 1986 Oct 01; 8(10):866-73. PubMed ID: 2944826
    [Abstract] [Full Text] [Related]

  • 11. Effects of atrial natriuretic peptide on transmural blood flow and reactive hyperemia in the presence of flow-limiting coronary stenosis in the awake dog: evidence for dilation of the intramural vasculature.
    Chu A, Stakely A, Lin CC, Cobb FR.
    Circ Res; 1989 Mar 01; 64(3):600-6. PubMed ID: 2521815
    [Abstract] [Full Text] [Related]

  • 12. Atrial natriuretic peptide decreases cardiac output independent of coronary vasoconstriction.
    Burnett JC, Rubanyi GM, Edwards BS, Schwab TR, Zimmerman RS, Vanhoutte PM.
    Proc Soc Exp Biol Med; 1987 Dec 01; 186(3):313-8. PubMed ID: 2962199
    [Abstract] [Full Text] [Related]

  • 13. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR, Neubauer S, Obitz G, Ertl G.
    J Mol Cell Cardiol; 1994 Apr 01; 26(4):527-37. PubMed ID: 8072008
    [Abstract] [Full Text] [Related]

  • 14. Adrenomedullin mediates coronary vasodilation through adenosine receptors and KATP channels.
    Sabates BL, Pigott JD, Choe EU, Cruz MP, Lippton HL, Hyman AL, Flint LM, Ferrara JJ.
    J Surg Res; 1997 Feb 01; 67(2):163-8. PubMed ID: 9073563
    [Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic peptide-induced relaxation of pre-constricted isolated rat perfused lungs: a comparison in control and hypoxia-adapted animals.
    Stewart AG, Thompson JS, Rogers TK, Morice AH.
    Clin Sci (Lond); 1991 Aug 01; 81(2):201-8. PubMed ID: 1653664
    [Abstract] [Full Text] [Related]

  • 16. Adenosine receptor blockade with 8-p-sulfophenyltheophylline aggravates coronary constriction.
    Martin SE, Tidmore WC, Patterson RE.
    Am J Physiol; 1991 Jun 01; 260(6 Pt 2):H1753-9. PubMed ID: 2058714
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise.
    Laxson DD, Homans DC, Bache RJ.
    Am J Physiol; 1993 Nov 01; 265(5 Pt 2):H1471-7. PubMed ID: 8238557
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular effects of intracoronary atrial natriuretic peptide administration in man.
    Herrmann HC, Rosenthal AD, Davis CA.
    Am Heart J; 1990 Aug 01; 120(2):308-15. PubMed ID: 2143351
    [Abstract] [Full Text] [Related]

  • 19. C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems.
    Wright RS, Wei CM, Kim CH, Kinoshita M, Matsuda Y, Aarhus LL, Burnett JC, Miller WL.
    J Am Coll Cardiol; 1996 Oct 01; 28(4):1031-8. PubMed ID: 8837586
    [Abstract] [Full Text] [Related]

  • 20. Alpha-human atrial natriuretic peptide is a coronary vasodilator in the Langendorff-perfused guinea pig heart.
    Otero HO, Wangler RD, Sparks HV, Chimoskey JE.
    Life Sci; 1988 Oct 01; 42(6):695-700. PubMed ID: 2963187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.